Trial Information
Calcifidol Therapy in Men With Cancer
Inclusion Criteria
Patients will be males with three successive rises in PSA after achieving a nadir
post-definitive therapy. The following criteria must be met: pathologically confirmed
prostate cancer, completion of definitive treatment in the form of local external beam
radiation or definitive surgery and three successive rises in PSA with no clinical
evidence of disease.
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Principal Investigator
Guy Howard, Ph.D
Authority:
United States: Federal Government
Study ID:
ONCO-09-99S
NCT ID:
NCT00018538
Start Date:
October 1999
Completion Date:
September 2002
Related Keywords:
- Prostate Cancer
- vitamin D
- prostatic neoplasms
- neoplasm recurrence
- Prostatic Neoplasms
Name | Location |
VAMC Miami, FL |
Miami, Florida 33125 |